LMO7-AS1

Across TCGA pan-cancer cohorts, LMO7-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LMO7-AS1 data layer compared with 2 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LMO7-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LMO7-AS1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and LUAD show a favorable association.

LUSC, OV, and LUAD are the cancer types where LMO7-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Quartile	All	0.876	0.530	.001	69	view →
OV	DFS	Median	IV	0.339	0.583	.002	54	view →
LUAD	DFS	Median	All	0.827	0.751	.003	46	view →
LGG	DFS	Median	All	0.325	0.473	<.001	44	view →
CESC	OS	Median	All	0.863	0.722	.002	38	view →
MESO	OS	Median	All	0.292	0.484	.006	34	view →
THCA	DFS	Tertile	III,IV	0.889	0.601	.009	26	view →
HNSC	DFS	Median	IV	0.719	0.562	.002	24	view →
SKCM	OS	Median	IV	0.762	0.319	.008	19	view →
UCS	DFS	Median	IV	0.909	0.416	.008	18	view →
UVM	DFS	Tertile	II,III,IV	0.313	0.675	.009	15	view →
GBM	DFS	Median	All	0.195	0.313	.005	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

LMO7-AS1–LUSC (DFS)

Open the LUSC breakdown →